Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Acadia Healthcare Company Inc (NASDAQ: ACHC) closed the day trading at $14.0 down -9.50% from the previous closing price of $15.47. In other words, the price has decreased by -$9.50 from its previous closing price. On the day, 2.98 million shares were traded. ACHC stock price reached its highest trading level at $15.4345 during the session, while it also had its lowest trading level at $13.8.
Ratios:
For a better understanding of ACHC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On December 03, 2025, BofA Securities Downgraded its rating to Underperform which previously was Neutral but kept the price unchanged to $13.
BofA Securities Downgraded its Buy to Neutral on September 10, 2025, while the target price for the stock was maintained at $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1292852224 and an Enterprise Value of 3928718848. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.88, and their Forward P/E ratio for the next fiscal year is 6.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 1.203 whereas that against EBITDA is 6.268.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.87, which has changed by -0.61198896 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $47.08, while it has fallen to a 52-week low of $12.63. The 50-Day Moving Average of the stock is -32.10%, while the 200-Day Moving Average is calculated to be -40.31%.
Shares Statistics:
Over the past 3-months, ACHC traded about 3.09M shares per day on average, while over the past 10 days, ACHC traded about 4213530 shares per day. A total of 90.43M shares are outstanding, with a floating share count of 89.34M. Insiders hold about 3.16% of the company’s shares, while institutions hold 124.77% stake in the company. Shares short for ACHC as of 1763078400 were 11646543 with a Short Ratio of 3.77, compared to 1760486400 on 12102934. Therefore, it implies a Short% of Shares Outstanding of 11646543 and a Short% of Float of 15.010001.
Earnings Estimates
A comprehensive evaluation of Acadia Healthcare Company Inc (ACHC) is underway, with the input of 10.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.34, with high estimates of $0.47 and low estimates of $0.19.
Analysts are recommending an EPS of between $2.38 and $1.94 for the fiscal current year, implying an average EPS of $2.09. EPS for the following year is $1.97, with 12.0 analysts recommending between $2.45 and $1.48.
Revenue Estimates
11 analysts predict $802.84M in revenue for. The current quarter. It ranges from a high estimate of $827.18M to a low estimate of $795.8M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $774.24MFor the next quarter, 11 analysts are estimating revenue of $817.16M. There is a high estimate of $835.1M for the next quarter, whereas the lowest estimate is $795.4M.
A total of 11 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.32B, while the lowest revenue estimate was $3.29B, resulting in an average revenue estimate of $3.29B. In the same quarter a year ago, actual revenue was $3.15BBased on 11 analysts’ estimates, the company’s revenue will be $3.44B in the next fiscal year. The high estimate is $3.48B and the low estimate is $3.39B.
